Abstract
Introduction
Basaloid is a rare and poorly-differentiated variant of squamous cell carcinoma of the larynx, with an invasive solid growth of cells in a lobular configuration. Different molecular markers, such as p53, Ki-67 and E-cadherin, have been shown to be prognostic factors in head and neck cancer.
Objective
To evaluate the relationship between the immunoexpression of p53, Ki-67 and E-cadherin in relation to prognosis in basaloid squamous cell carcinoma of the larynx (BSCCL)
Patients and methods
We retrospectively studied 11 cases of BSCCL, all male with a mean age of 62.4 years. Immunohistochemical analyses were performed on paraffin-embedded tissues using p53 (DO-7), Ki-67 (MIB-1) and E-cadherin (56B5) antibodies. Quantitative assessments of the expression and descriptive statistical analyses were performed.
Results
In 72.7% of the cases, clinically advanced stages III–IV were diagnosed. Average survival time was 56.09 months, and 72.7% of patients died as a consequence of the tumour. Immunoreactivity of p53 (>10% of cells) was detected in the 81.8% of the cases. The 72.7% of the cases showed overexpression of Ki-67 (>50% of cells). The cases with low immunoexpression of Ki-67 and p53 had the best clinicopathological data. All cases showed a decreased expression of E-cadherin.
Conclusions
BSCCL is an aggressive variant of the squamous cell carcinoma and has a high expression of p53 and Ki-67 with a low expression of E-cadherin. These results could be related to the aggressiveness of the disease and its poor prognosis.
Similar content being viewed by others
References
Wain SL, Kier R, Vollmer RT, Bossen EH. Basaloid-squamous carcinoma of the tongue, hipopharynx and larynx: Report of 10 cases. Human Pathol. 1986;17:1158–66.
Tsubochi H, Suzuki T, Suzuki S, et al. Immunohistochemical study of basaloid squamous cell carcinoma, adenoid cystic and mucoepidermoid carcinoma in the upper aerodigestive tract. Anticancer Res. 2000;20:1205–12.
Saltarelli MG, Fleming MV, Weing BM, Gal AA, Mansour KA, Travis WD. Primary basaloid squamous cell carcinoma of the trachea. Am J Clin Pathol. 1995;104:594–8.
Barnes L, Ferlito A, Altavilla G, MacMillan C, Rinaldo A, Doglioni C. Basaloid squamous cell carcinoma of the head and neck: clinicopathological features and differential diagnosis. Ann Otol Rhinol Laryngol. 1996;105: 75–82.
Ferlito A, Altavilla G, Rinaldo A, Doglioni C. Basaloid squamous cell carcinoma of the larynx and hypopharynx. Ann Otol Rhinol Laryngol. 1997;106:1024–35.
Ereño C, López JI, Sánchez JM, Toledo JD. Basaloidsquamous cell carcinoma of the larynx and hypolarynx. A clinicopathologic study of 7 cases. Pathol Res Pract. 1994;190:186–93.
Paulino AF, Singh B, Shah JP, Huvos AG. Basaloid squamous cell carcinoma of the head and neck. Laryngoscope. 2000;110:1479–82.
Luna MA, El-Naggar A, Parichatikanond P, Weher RS, Batsakis JG. Basaloid squamous carcinoma of the upper aerodigestive tract: clinicopathologic and DNA flow cytometric analysis. Cancer. 1990;66:2528–31.
Shin DM, Lee JS, Lippman SM, et al. p53 Expression: Predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J Natl Cancer Int. 1996;88:519–29.
Sittle C, Eckel HE, Damm M, von Pritzbuer E, Kvasnicka HM. Ki-67 (MIB-1), p53, and Lewis-X (Leu M1) as pronostic factors of recurrence in T1 and T2 laryngeal carcinoma. Laryngoscope. 2000;110:1012–7.
Lera J, Lara P, Pérez S, Cabrera J, Santana C. Tumor proliferation, p53 expression and apoptosis in laryngeal carcinoma. Relation to the results of rathiotheraphy. Cancer. 1998;83:2493–501.
Gerdes J, Lemke H, Barsch H, Hans H, Schwab U, Stein H. Cell cycle analysis of a cell-proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunology. 1984;133:1710–5.
Pérez A, García T, Lozano A, et al. The relationship between survival and cell proliferation index in squamous cell carcinoma of larynx. Rev Laryngol Otol Rhinol. 2000;121:121–5.
Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251:1451–5.
Schipper JH, Frisen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. E-cadherin expression in squamous cell carcinoma of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 1991;51:6328–37.
Banks ER, Frieson HF Jr, Mills SE, George E, Zarbo RJ, Swanson PE. Basaloid squamous cell carcinoma of the head and neck. A clinicopathology and immunohistochemical study of 40 cases. Am J Surg Pathol. 1992;16:939–46.
Akyol M, Dursun A, Akyol G, Edah N. Proliferating cell nuclear antigen immunoreactivity and the presence of p53 mutation in basaloid squamous cell carcinoma of the larynx. Oncology. 1998;55:382–3.
Anneroth G, Hansen L. A methodologic study of histologic classification and grading malignancy in oral squamous cell carcinoma. Scand J Dent Res. 1984;92:448–68.
Norton AJ, Jordan S, Yeomans P. Brief. High—temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol. 1994;173:371–9.
Wizenburg SM, Niehans GA, George E, Daly K, Adams GL. Basaloid squamous carcinoma: a clinical comparision of two histologic types with poorly differentiatiated squamous cell carcinoma. Otolaryngol Head Neck Surg. 1998;119:471–5.
Tzung-Shiah S, Yih-Leong C, Jenq-Yuh K, Chen-Tu W, Shiann-Yann L. Basaloid squamous cell carcinoma of the larynx. Otolaryngol Head Neck Surg. 1999;121:647–50.
Bracero F, Gamiz MJ, Soldado L, et al. Hypopharynx and larynx basaloid squamous carcinoma: our experience with 6 cases. Acta Otorrinolaringol Esp. 2001;52:229–36.
Owonikoko T, Loberg C, Gabbert HE, Sarbia M. Comparative analysis of basaloid and typical squamous cell carcinoma of the oesophagus: a molecular biological and immunohistochemical study. J Patho. 2001;193: 155–61.
Pignataro L, Capaccio P, Pruneri G, et al. The predictive value p53, MDM-2, cyclin D1 and Ki-67 in the progresión from low-grade dysplasia towards carcinoma of the larynx. J Laryngol Otol. 1998;112:455–9.
Ruíz-Godoy L, Meneses A, Suchil L, Barrera J, Mosqueda A. Carcinoma epidermoide basaloide del tracto aerodigestivo superior. Med Oral. 1997;2:135–9.
Grandi C, Aloisio N, Moglia D, et al. Prognostic significance of lymphatic spread in head and neck carcinomas: Therapeutic implications. Head Neck Surg. 1985; 8:67–73.
Takes R, Baatenburg R, Wijffels K, et al. Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer. J Pathol. 2001:194:298–302.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rodríguez Tojo, M.J., García Cano, F.J., Infante Sánchez, J.C. et al. Immunoexpression of p53, Ki-67 and E-cadherin in basaloid squamous cell carcinoma of the larynx. Clin Transl Oncol 7, 110–114 (2005). https://doi.org/10.1007/BF02708743
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02708743